[ORGANIZATION]
Teva Pharmaceuticals
Featured in 5 tracked stories · first seen
Situations
FDA approval of Weltruza for schizophrenia
2 clusters · 6 sources · last updated
Latest: FDA approves Weltruza monthly subcutaneous olanzapine injection
The U.S. Food and Drug Administration (FDA) has approved Weltruza, a once-monthly subcutaneous olanzapine injection for the treatment of schizophrenia in adults. Developed by Teva Pharmaceutical Industries in partnership
Also covered in
-
Lupin appoints Brian Savage as President and Chief Legal Officer
[BUSINESS] · 3 sources ·
-
Royal College of Nursing ends partnership with Teva UK
[POLITICS] · 3 sources ·
-
Teva Pharmaceuticals faces antitrust investigation
[BUSINESS] · 3 sources ·